Skip to main content
. 2015 Jan 8;36(15):924–931. doi: 10.1093/eurheartj/ehu462

Table 2.

Association between presentation blood glucose and 30-day mortality

Group Outcome Presentation blood glucose (mmol/L) Events/patients Rate per 100 pyrs (95% CI) Adjusted HR (95%CI) P-value
Pre-existing diabetes All-cause mortality 3.9–6.1 81/1271 6.4 (5.1–7.9) Referent NA
>6.1–7.8 105/1457 7.2 (5.9–8.7) 1.13 (0.82–1.56) 0.446
>7.8–9.4 78/1254 6.2 (4.9–7.8) 1.21 (0.86–1.70) 0.284
>9.4–11.1 56/981 5.7 (4.3–7.4) 0.96 (0.66–1.39) 0.821
>11.1 196/2286 8.6 (7.4–9.9) 1.48 (1.10–2.00) 0.010
Cardiovascular mortality 3.9–6.1 44/1271 3.5 (2.5–4.7) Referent NA
>6.1–7.8 62/1457 4.3 (3.3–5.5) 1.21 (0.80–1.83) 0.373
>7.8–9.4 46/1254 3.7 (2.7–4.9) 1.16 (0.74–1.82) 0.517
>9.4–11.1 31/981 3.2 (2.2–4.5) 0.90 (0.55–1.48) 0.683
>11.1 114/2286 5.0 (4.1–6.0) 1.44 (0.97–2.14) 0.068
No pre-existing diabetes All-cause mortality 3.9–6.1 270/4023 6.7 (5.9–7.6) Referent NA
>6.1–7.8 273/3089 8.8 (7.8–10.0) 1.26 (1.05–1.50) 0.013
>7.8–9.4 150/1171 12.8 (10.8–15.0) 1.47 (1.18–1.82) <0.001
>9.4–11.1 60/468 12.8 (9.8–16.5) 1.41 (1.04–1.90) 0.027
>11.1 83/524 15.8 (12.6–19.6) 1.50 (1.11–2.02) 0.008
Cardiovascular mortality 3.9–6.1 182/4023 4.5 (3.9–5.2) Referent NA
>6.1–7.8 190/3089 6.2 (5.3–7.1) 1.28 (1.03–1.59) 0.024
>7.8–9.4 103/1171 8.8 (7.2–10.7) 1.54 (1.18–1.99) 0.001
>9.4–11.1 44/468 9.4 (6.8–12.6) 1.64 (1.16–2.33) 0.006
>11.1 58/524 11.1 (8.4–14.3) 1.51 (1.05–2.18) 0.025

pyrs, person-years.